ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1 | -99.9% | 24 | +50.0% | 0.00% | – |
Q3 2022 | $1,000 | -90.9% | 16 | -87.5% | 0.00% | – |
Q2 2022 | $11,000 | +1000.0% | 128 | +1180.0% | 0.00% | – |
Q1 2022 | $1,000 | -66.7% | 10 | -65.5% | 0.00% | – |
Q4 2021 | $3,000 | -50.0% | 29 | -42.0% | 0.00% | – |
Q2 2021 | $6,000 | 0.0% | 50 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -45.5% | 50 | -50.0% | 0.00% | – |
Q1 2020 | $11,000 | -21.4% | 100 | 0.0% | 0.00% | – |
Q4 2019 | $14,000 | +40.0% | 100 | 0.0% | 0.00% | – |
Q3 2019 | $10,000 | -16.7% | 100 | 0.0% | 0.00% | – |
Q2 2019 | $12,000 | 0.0% | 100 | 0.0% | 0.00% | – |
Q1 2019 | $12,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |